Annual Report for the Financial Year 2024-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Globalspace Technologies Ltd has submitted its Annual Report for FY 2024-2025 to BSE as required under Regulation 34(1) of the Listing Regulations. The 15th Annual General Meeting is scheduled for September 29, 2025, at 3:30 PM via video conferencing. The company's key focus areas include its AI-powered healthcare platforms DocExa and MediOla, along with the integrated Innopharm Healthcare acquisition. Key business items at the AGM include reappointment of the Managing Director, appointment of statutory auditors for a 2-year term, appointment of secretarial auditors for 5 years, approval of MD remuneration of ₹48 lakhs per annum, and appointment of a new Independent Director.
This is a routine regulatory filing of the annual report — no immediate impact on stock price. Shareholders should review the full annual report for financial performance details and note the AGM date for voting on key resolutions including auditor appointments and director remuneration.